Herbert-Herman Cancer Center, Sparrow Hospital

Lansing, Michigan 48912

1 studies enrolling now · 4 studies all time

What they study most

Angiosarcoma, Breast Cancer, Breast Neoplasms, Breast Tumors, Early-stage Breast Cancer, HER2-negative Breast Cancer, HER2-positive Breast Cancer, Hormone Receptor Negative Tumor, Hormone Receptor Positive Tumor, Locally Advanced Breast Cancer, Locally Recurrent Breast Cancer, Metastatic Breast Cancer

Studies at this site

• I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer — Recruiting now
• Pivotal Study in HER2 Negative, Locally Recurrent or Metastatic Breast Cancer — Stopped early
• Study of Neoadjuvant Chemotherapy Plus Trastuzumab and Pertuzumab in HER2-Negative Breast Cancer Patients With Abnormal HER2 Signaling — Status unconfirmed
• Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100) — Stopped early